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Protein glutathionylationFriedreich's ataxia (FRDA) is a neurodegenerative disease caused by low levels of the mitochondrial protein
frataxin. The main phenotypic features of frataxin-deﬁcient human and yeast cells include iron accumulation
in mitochondria, iron–sulfur cluster defects and high sensitivity to oxidative stress. Frataxin deﬁciency is also
associated with severe impairment of glutathione homeostasis and changes in glutathione-dependent
antioxidant defenses. The potential biological consequences of oxidative stress and changes in glutathione
levels associated with frataxin deﬁciency include the oxidation of susceptible protein thiols and reversible
binding of glutathione to the •SH of proteins by S-glutathionylation. In this study, we isolated mitochondria
from frataxin-deﬁcient Δyfh1 yeast cells and lymphoblasts of FRDA patients, and show evidence for a severe
mitochondrial glutathione-dependent oxidative stress, with a low GSH/GSSG ratio, and thiol modiﬁcations
of key mitochondrial enzymes. Both yeast and human frataxin-deﬁcient cells had abnormally high levels of
mitochondrial proteins binding an anti-glutathione antibody. Moreover, proteomics and immunodetection
experiments provided evidence of thiol oxidation inα-ketoglutarate dehydrogenase (KGDH) or subunits of
respiratory chain complexes III and IV. We also found dramatic changes in GSH/GSSG ratio and thiol
modiﬁcations on aconitase and KGDH in the lymphoblasts of FRDA patients. Our data for yeast cells
also conﬁrm the existence of a signaling and/or regulatory process involving both iron and glutathione.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Cellular thiol redox state is a crucial mediator of multiple meta-
bolic, signaling and transcriptional processes, and a balance between
oxidative and reducing conditions is essential for the normal function
and survival of cells. Free GSH is a limiting factor in many detoxiﬁ-
cation processes, in which it protects protein thiol groups from
oxidation either directly, as a free radical scavenger, or indirectly,
as a co-substrate for a number of important enzymatic systems.
Glutathione can also form a mixed-disulﬁde bridge with an accessible
free thiol group on a protein, a process called S-glutathionylation
[1–5]. This may occur through oxidation of a protein-thiol group in
response to ROS, and reaction with GSH or, alternatively, oxidized
GSSG may react with protein–SH groups. Glutathionylation protects
cysteine thiols against irreversible oxidation but also results ined glutathione; GSSG, oxidized
lutarate dehydrogenase; ISDH,
; YNB, yeast nitrogen base
: +33 1 57 27 81 35.
derot.fr (F. Auchère).
l rights reserved.protein-speciﬁc functional changes that play an important role in the
response of cells to oxidative damage and in redox signaling [4,6–15].
Interest in protein glutathionylation has recently increased, with
the possible implication of this process in human diseases and the
recognition of glutathione as a regulatory molecule and sensor of
the redox state of cells [2,4,9,11,12,16–20]. Glutathionylation may
be an important redox signaling mechanism allowing cells to sense
and to signal harmful stress conditions and to trigger an apoptotic re-
sponse. This dynamic process occurs both in normal physiological
conditions and after exposure to oxidative stress. In the absence of
stress, reversible glutathionylation modulates protein activity, by ac-
tivating or inactivating certain enzymes and transcription factors
[11]. As mitochondria play a key role in oxidative damage to the cell
and redox signaling, changes in protein thiol redox state during
oxidative stress are thought to be particularly important in these
organelles [9,21].
Friedreich's ataxia (FRDA) is a neurodegenerative disease charac-
terized by progressive neurodegeneration and cardiomyopathy
caused by a decrease in levels of the mitochondrial protein frataxin
[22,23]. The principal cellular phenotypes of this disease include
iron accumulation in mitochondria, defects in mitochondrial respira-
tion, iron–sulfur clusters and heme synthesis, and high levels of
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various studies, including some by our group, have shown that
frataxin deﬁciency is associated with a severe impairment of glu-
tathione homeostasis and changes to glutathione-dependent anti-
oxidant defenses [28–33]. Moreover, protein glutathionylation has
recently been identiﬁed as a possible means of protein redox function
regulation in FRDA. Indeed, particularly high levels of actin ﬁlaments
glutathionylation have been observed, together with cytoskeletal
abnormalities, in ﬁbroblasts from FRDA patients, probably in response
to the stress conditions induced by frataxin deﬁciency [31–33]. One
recent study also provided evidence for abnormal protein glutathio-
nylation in several structures of the spinal cord in patients with
FRDA [34].
In recent years, evidence for a link between glutathione and iron
pathways has emerged [35–40]. In yeast, high-afﬁnity iron uptake is
regulated at the transcriptional level by Aft1. In conditions of iron
sufﬁciency, Aft1 is located in the cytosol. However, in conditions of
iron deﬁciency, the protein is shuttled to the nucleus, where it
activates the transcription of “iron regulon” genes. Aft1-dependent
activation of the “iron regulon” is constitutive in yeast frataxin-
deﬁcient cells, despite the iron accumulation observed in these cells
[41]. The mechanism by which Aft1 senses iron is unknown, but
various studies have highlighted the critical role of yeast glutare-
doxins 3 and 4 in Aft1 function in yeast cells [37,42,43].
In this work, we focused on isolated mitochondria and studied the
glutathione levels in yeast Δyfh1 cells and lymphoblasts from FRDA
patients. We found that frataxin-deﬁcient yeast cells and lympho-
blasts from patients with FRDA were subject to mitochondrial oxida-
tive stress and displayed a signiﬁcant decrease in mitochondrial
GSH/GSSG ratio. Both yeast and human frataxin-deﬁcient cells con-
tained abnormally high levels of proteins binding an anti-glutathione
antibody. In addition, proteomics and immunodetection experiments
revealed that key mitochondrial proteins, such as aconitase, KGDH or
subunits of respiratory chain complexes III and IV, present thiol oxida-
tion, and suggest that some of these proteins may be glutathionylated.
Our ﬁndings also conﬁrm the existence of a signaling and/or regulatory
process involving both iron and glutathione in yeast cells.
2. Materials and methods
2.1. Yeast strains, media and growth conditions
The Saccharomyces cerevisiae strains used were S150-2B (MATa,
his3-Δ1, leu2-3112, trp1-289, ura3-52) and S150-2BΔyfh1 (Δyfh1::
TRP1) [44]. Unless otherwise stated, cells were grown aerobically at
30 °C in minimal YNB (yeast nitrogen base, Bio 101, Inc., 2% D-glucose)
supplemented with the necessary amino acids. We also used YPR (1%
yeast extract, 1% bacto TM peptone, 2% rafﬁnose, 0.1% glucose). We
checked the integrity of themitochondrial DNA of our cells (rho status),
by crossing them with a rho0 tester strain (Matα, rho−). The resulting
diploid clones were selected on minimal medium and we assessed
their ability to grow on a nonfermentable carbon source (glycerol).
More than 90% of cells were rho+.
2.2. Determination of protein content
We used the Bradford protein assay to determine the protein
content of isolated mitochondria, with bovine serum albumin as the
standard. Enzyme activities are expressed per milligram of protein.
2.3. Isolation of yeast mitochondria
Yeast cells were cultured overnight at 30 °C in YNRmedium (yeast
nitrogen base, 2% rafﬁnose, 0.1% glucose and amino acids) and har-
vested by centrifugation at 4000 g for 10 min at 4 °C, washed with
50 ml of ice-cold water and resuspended in 0.6 M sorbitol, 50 mMTris–HCl, pH 7.5 supplemented with complete protease inhibitor
mixture (Sigma). We added about 4 ml of 0.45 mm diameter sterile
glass beads to each tube and the cells were lysed by vortexing six
times for 30 s each, at 2 min intervals, on ice. All subsequent steps
were carried out at 4 °C. Glass beads and unbroken cells were re-
moved by centrifugation at 4000 g for 10 min, supernatants were
centrifuged (14,000 g, 10 min, 4 °C) and the resulting pellets were
resuspended in 0.6 M sorbitol, 50 mM Tris–HCl, pH 7.5 for the
preparation of mitochondrial protein extracts, the supernatants
constituting the cytosolic fractions. Puriﬁed mitochondria were
immediately frozen at −80 °C. In our conditions, mitochondrial
proteins accounted for 8% of cellular proteins.
2.4. Human cell cultures and isolation of mitochondria
Lymphoblasts from two clinically affected FRDA patients and from
two age- and sex-matched control donors were obtained from CRICM
(the DNA and cell bank INSERM U975). The patients were homozy-
gous for the GAA expansion in the FXN gene; one was homozygous
for an expansion of 2.4 kb and the other had an expansion of 2.5 kb in
one allele and an expansion of 2.6 kb in the other. Lymphoblast cell
lines were cultured in RPMI 1640 medium supplemented with 15%
fetal bovine serum (FBS), L-glutamine (1%), penicillin/streptomycin
cocktail (1%), and HEPES (16 mM, pH 7.35, 37 °C). All cell lines were
cultured in a humidiﬁed atmosphere containing 5% CO2, 95% air. Cells
were resuspended in isolation buffer (210 mM mannitol, 70 mM
sucrose, 1 mM EDTA, 5 mM HEPES, pH 7.2). Digitonin (10% w/v in
DMSO) was added slowly, to a ﬁnal concentration of 0.2 to 0.4 mg/ml.
Permeabilized cells were collected by centrifugation and disrupted in
a glass Dounce homogenizer. Cell debris and nuclei were removed by
centrifugation for 5 min at 625 g. The ﬁnal supernatant was spun at
10,000 g for 20 min to obtain the mitochondrial pellet. For assessment
of the levels of frataxin in the patient's lymphoblasts, we generated
anti-rabbit polyclonal antibodies against human frataxin residues
162–176.
2.5. Determination of cytosolic and mitochondrial glutathione levels
Glutathione levels were determined with a modiﬁed version of
the recycling enzymatic assay, as previously described [28,45]. Speciﬁc
glutathione content was calculated from standard curves obtained
with various concentrations of GSSG, and is expressed in nmol of
glutathione/mg of protein. The assay is based on the reduction of
each GSSG molecule to give two GSH molecules, and the reading
is in GSSG equivalents because GSSG is used as the standard, so the
total measured speciﬁc glutathione content is 0.5 GSH+GSSG. For the
quantiﬁcation of oxidized glutathione (GSSG), samples (including
GSSG standards) were treated with 2% (vol/vol) 4-vinylpyridine for
1 h at room temperature before analysis. The cytosolic and mitochon-
drial GSH/GSSG ratios were calculated as follows: GSH/GSSG=2
[(total glutathione)−GSSG]/GSSG. All the data points shown in the ﬁg-
ures and the values given are means of at least three determinations.
2.6. Detection of carbonylated proteins
Carbonylated proteins were detected and analyzed after the deriva-
tization of protein carbonyl groups with 2,4-dinitrophenylhydrazine
(Protein Oxidation Detection Kit, OxyBlot™, Millipore). Derivatized
samples were incubated in Laemmli sample buffer for 5 min at 100 °C,
resolved by SDS-PAGE in a 4–20% acrylamide gel and electrotransferred
onto a Hybond nitrocellulose membrane (Amersham Pharmacia Bio-
tech, Piscataway, USA). The primary antibody for western blotting was
raised against dinitrophenylhydrazone, and primary antibody binding
was detected with a peroxidase-conjugated secondary antibody and a
chemiluminescent substrate (ECL plus western blotting detection
system, GE Healthcare).
214 A.L. Bulteau et al. / Biochimica et Biophysica Acta 1822 (2012) 212–2252.7. Measurement of 20S-proteasome peptidase and mitochondrial
proteolytic activity
The chymotrypsin-like activity of the 20S-proteasome was
assayed with the ﬂuorogenic peptide succinyl-Leu-Leu-Val-Tyr-amido-
methylcoumarin (LLVY-AMC), as previously described [46]. All data
points in the ﬁgures and the values given are the means of at least
three determinations, and Student's t test was used to identify sig-
niﬁcant differences. Proteolytic activity was assessed as the rate of
ﬂuorescein isothiocyanate (FITC)-casein degradation, as previously
described [46].
2.8. Assay for aconitase activity
Mitochondria were suspended in 25 mM phosphate buffer pH
7.25 supplemented with 0.05% Triton X-100 and aconitase activity
was assayed spectrophotometrically at 340 nm, as previously described
[46]. Where indicated, glutaredoxin (1 U/ml, Calbiochem) was added
before enzyme analysis. The results are expressed in μmol of reduced
NADPH/min/mg protein, and all data points in the ﬁgures are the
means of at least three determinations.
2.9. Assay for α-ketoglutarate dehydrogenase (KGDH) activity
Mitochondria were suspended in 25 mMMOPS, 0.05% Triton X-100,
pH 7.4, and α-ketoglutarate dehydrogenase activity was assayed spec-
trophotometrically as the rate of NAD+ reduction to NADH upon ad-
dition of 5 mMMgCl2, 2.5 mM α-ketoglutarate, 0.1 mM CoASH, 0.2 mM
thiamine pyrophosphate, and 1 mM NAD+, as previously described
[47]. The results are expressed in nmol of reduced NADH/min/mg
protein, and all data points in the ﬁgures are means of at least three de-
terminations.Where indicated, glutaredoxin (1 U/ml, Calbiochem)was
added before enzyme analysis.
2.10. Assay for isocitrate dehydrogenase (ISDH) activity
Mitochondria were diluted in 25 mM MOPS, 0.05% Triton X-100,
pH 7.4, containing 2 mM NADP+, 2 mM MgCl2 and 5 mM isocitrate.
The activity of ISDHwasmeasured by following the NADPH production
at 340 nm and 25 °C. One unit of ISDH activity is deﬁned as the amount
of enzyme catalyzing the production of 1 μmol of NADPH/min and all
data points in the ﬁgures and the values listed are means of at least
three determinations. Where indicated, glutaredoxin (1 U/ml, Calbio-
chem) was added prior to enzyme analysis.
2.11. Assay for ubiquinol-cytochrome c oxidoreductase (complex III) and
cytochrome c oxidase (complex IV) activities
Ubiquinol-cytochrome c oxidoreductase activity was determined
as previously described [48], with a synthetic analog of ubiquinol,
decylubiquinol (DBH2, 100 μM) as the electron donor, and is expressed
in nmol of reduced cytochrome c/min/mg protein. Complex IV activity
(cytochrome c oxidase) was measured as previously described [48].
Where indicated, glutaredoxin (1 U/ml, Calbiochem) was added be-
fore enzyme analysis.
2.12. Mitochondrial respiration
The respiratory activity of isolated mitochondria was evaluated by
an oxypolarographic method. The rate of oxygen consumption was
measured in a 1 ml thermostatically controlled cell equipped with a
Clark-type electrode, with Oxygraph plus V 1.01 software (Hansatech
Instruments). The apparatus was calibrated with sodium dithionite
before analysis. The oxygen consumption of isolated mitochondria
was measured in 10 mM Tris–HCl buffer pH 6.8, supplemented with
0.65 M sorbitol, 0.36 mM EDTA, 10 mM KCl and 10 mM KH2PO4 andsaturated with air at 30 °C (234 nmol O2/ml). The electron donor for
respiration was NADH (10 mM), succinate (10 mM), or pyruvate/
malate (10 mM/2.5 mM). Rates of oxygen consumption are expressed
in nmol oxygen/min/mg protein, and all values given are means of at
least three determinations.
2.13. Detection of glutathione–protein adducts with an
anti-glutathione antibody
For SDS-PAGE, mitochondrial protein samples were suspended in
nonreducing loading buffer and separated on 12% gels in a Biorad
Mini Protean system. The protein bands were then transferred to a ni-
trocellulose membrane. The blot was incubated with a mouse mono-
clonal antibody against glutathionylated proteins (Virogen Corp,
USA), followed by a secondary antibody-horseradish peroxidase
conjugate, which was visualized by enhanced chemiluminescence
(ECL plus, GE Healthcare, USA).
2.14. Puriﬁcation and immunodetection of glutathionylated
mitochondrial proteins
Glutathionylated proteins were puriﬁed with a modiﬁed version
of a previously described “biotin/Grx-switch” procedure [47]. Mito-
chondria were solubilized by incubation with 0.05% Triton X-100
and treated with N-ethylmaleimide (NEM, 0.5 mM) for 30 min, for
derivatization of the free reduced sulfhydryl groups on proteins.
Unreacted NEM was removed by scavenging with N-acetylcysteine
(NAC, 0.6 mM, 15 min) and samples were incubated for 1 h with
glutaredoxin (2 U/ml) in the presence of GSH (0.5 mM) to reduce
•SH groups that had undergone glutathionylation. Following treat-
ment with 1.5 mM maleimide-PEG2-biotin (Thermoscientiﬁc, Rock-
ford, USA) for 10 min to label newly exposed sulfhydryl groups,
excess maleimide-PEG2-biotin was removed by scavenging with NAC
(1.8 mM). Biotinylated and nonbiotinylated proteins were then sepa-
rated on 100 μl of high-afﬁnity streptavidin-agarose resin that had
been washed with 50 mM Tris–HCl buffer pH 7.5 (0.6 M sorbitol).
After incubation with the resin for 30 min, the suspension was centri-
fuged at 750 g for 1 min to pellet the streptavidin agarose beads. The
supernatant was collected and 100 mM DTT was added before western
blotting to investigate the proteins not binding to streptavidin. For
identiﬁcation of the proteins that bound to the streptavidin agarose
beads, the pellet was washed, the biotin-protein conjugate formed
was cleaved by reduction and the protein was dissociated from the
beads by adding 1× gel electrophoresis buffer containing 100 mM
DTT. The sample was centrifuged for 1 min at 750 g, and the superna-
tant was collected for western blot analysis.
The biotinylated (bound to the resin) and nonbiotinylated (not
bound to the resin) fractions were resolved by gel electrophoresis
and the proteins were transferred to a nitrocellulose membrane. We
generated anti-rabbit polyclonal antibodies against yeast mitochon-
drial aconitase, targeting residues 495–511, and against Pim1, target-
ing residues 337–353, as previously described [46]. We detected the
subunits of KGDH with antibodies against the E1, E2 and E3 subunits,
generously provided by Dr Luke Szweda (OklahomaMedical Research
Foundation, USA). Complexes III and IV of the respiratory chain were
detected with antibodies against the bc1 complex and cytochrome c
oxidase, generously provided by Dr Grazia Izaya (Mayo Clinic, USA).
2.15. Mass spectrometry analyses. Trypsic digestion and
nanoLC fractionation
The streptavidin agarose beads (with bound biotinylated pro-
teins) were processed for mass spectrometry as follows: the beads
were resuspended in 50 mM ammonium acetate pH 7.5 supplemen-
ted with 2 μg/100 μl trypsin (Sigma, proteomic grade) and incubated
overnight at 37 °C. The beads were removed by centrifugation and the
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nanoLC. The samples were separated on an Ultimate 3000 nano-LC
system (Dionex, Sunnyvale, USA), using a C18 column (PepMap100,
3 μm, 100 Å, 75 μm id×15 cm, Dionex) at a ﬂow rate of 300 nl/min.
Buffer A was 2% acetonitrile (ACN) in water plus 0.05% triﬂuoroacetic
acid (TFA) and buffer B was 80% ACN in water plus 0.04% TFA. Pep-
tides were desalted on the precolumn for 3 min, in buffer A alone.
They were then separated over a 60 min period on the following gra-
dient: 0 to 20% B over 10 min, 20% to 55% B over 45 min and 55% to
100% B over 5 min. Chromatograms were recorded at a wavelength
of 214 nm. Peptide fractions were collected with a Probot microfrac-
tion collector (Dionex). CHCA (LaserBioLabs, Sophia-Antipolis,
France) was used as the MALDI matrix. The matrix (2 mg/ml in 70%
ACN in water supplemented with 0.1% TFA) was continually added
to the column efﬂuent via a micro “T” mixing piece, at a ﬂow rate of
1.2 μl/min. After a 14-min run, a start signal was sent to the Probot
to initiate fractionation. Each fraction was collected over a period of
10s and spotted onto a MALDI sample plate (1664 spots per plate, Ap-
plied Biosystems, Foster City, CA).
2.16. MALDI MS and MSMS
MS and MS/MS analyses of off-line-spotted peptide samples were
carried out on a 4800+ MALDI-TOF/TOF Analyzer (Applied Biosys-
tems). After screening of all LC-MALDI sample positions in MS-
positive reﬂector mode, with 1500 laser shots, the automatically se-
lected precursors were fragmented at a collision energy of 1 kV,
using air as the collision gas (pressure of ~2×10−6 Torr). MS spectra
were acquired at m/z values between 800 and 4000. For internal cal-
ibration, we used the parent ion of Glu1-ﬁbrinopeptide at an m/z
1570.677 diluted in the matrix (3 fmol per spot). Up to 12 of the
most intense ion signals per spot position, with S/N>12, were select-
ed as precursors for MS/MS acquisition. Peptides and proteins were
identiﬁed with GPS™ Software V 3.1 (Applied Biosystems), using
the Mascot algorithm. We used each MS/MS spectrum as a query
against the Uniprot/Swissprot database (release 57 of January 2010,
6569 entries for S. cerevisiae) for S. cerevisiae species. Searches were
carried out with various modiﬁcations of oxidized methionine and
N-ethyl-maleimide-labeled cysteine parameters enabled. The Mascot
search engine was used, with a tolerance of one incorrect cleavage
during trypsin digestion, a precursor ion mass accuracy of 50 ppm
and a fragment ion mass accuracy of 0.3 Da. Protein identiﬁcations
were based on the acceptance of MS/MS spectra with an expectation
valueb10−4, as such spectra made the greatest contribution to over-
all Mascot score.
3. Results
3.1. Yeast and human frataxin-deﬁcient cells are subject to severe
mitochondrial glutathione-dependent oxidative stress
Mitochondrial and cytosolic GSH/GSSG ratios may vary indepen-
dently, and changes in these ratios contribute to the response of mi-
tochondria to redox signals and oxidative damage [49]. Glutathione
cannot be synthesized within yeast mitochondria and must be
imported into the mitochondrial matrix from the cytosol. We deter-
mined total glutathione (reduced+oxidized forms) and glutathione
disulﬁde (GSSG) levels in cytosolic fractions and isolated mitochon-
dria, in yeast wild-type and frataxin-deﬁcient cells. In wild-type
cells, glutathione was present mostly in the cytosol (Fig. 1A). In addi-
tion, the high cytosolic GSH/GSSG ratio indicates that most of the in-
tracellular free glutathione was in the reduced (GSH) form,
preventing the formation of toxic mixed disulﬁde-protein products.
In contrast, mutant cells had a speciﬁc cytosolic glutathione content
62% lower than that of wild-type cells (Fig. 1) that could not be
accounted for by a decrease in the expression of genes involved inglutathione synthesis, as previously reported [28]. In addition, the mi-
tochondrial speciﬁc glutathione content of Δyfh1 cells was higher
than that of wild-type cells (Fig. 1A and Table 1). The mitochondrial
GSH/GSSG ratio was also lower in Δyfh1 cells, indicating that the
cells were subject to severe mitochondrial oxidative stress.
We cultured lymphoblasts from FRDA patients (with very low fra-
taxin levels) and controls. There was no signiﬁcant difference in total
mitochondrial glutathione levels between the cells of controls and pa-
tients (Table 1), consistent with previous data obtained for FRDA ﬁ-
broblasts [30]. However, the GSH/GSSG ratio was 12.0 in control
lymphoblasts and 2.8 in FRDA patients, reﬂecting chronic mitochon-
drial oxidative stress in the lymphoblasts of the patients and higher
levels of oxidized glutathione disulﬁde in the mitochondria.
3.2. Iron induces a change in the cellular distribution of glutathione in
yeast frataxin-deﬁcient cells
The culture of cells in the presence of a 100 μM excess of iron led
to a signiﬁcant increase in speciﬁc mitochondrial glutathione content
in wild-type cells (Fig. 1B). However, the mitochondrial GSH/GSSG
ratio remained similar to that in standard growth medium (which
contains 1 μM iron; Table 1). Frataxin-deﬁcient cells responded dif-
ferently to iron overload conditions, with no signiﬁcant changes in
glutathione levels in the cytosol, and an increase in GSH/GSSG ratio,
corresponding to a decrease in cytosolic GSSG content. Mitochondrial
glutathione speciﬁc content was 2-fold increased, but the mitochon-
drial GSH/GSSG ratio of 4.8 revealed that mutant cells remained in
conditions of severe mitochondrial oxidative stress (Table 1).
3.3. Effect of excess iron on the distribution of oxidized proteins, 20S-
proteasome and Lon protease activities
Oxidative processes lead to irreversible chemical modiﬁcations
through protein carbonylation, an early marker of oxidative stress.
Frataxin deﬁciency results in the accumulation of proteins that have
undergone oxidative modiﬁcation in mitochondria, activation of the
Lon protease and inhibition of the chymotrypsin-like activity of the
20S-proteasome [46]. These proteases are in charge of the clearance
of oxidized proteins and activation of Lon protease and proteasome
inhibition are hallmark of oxidative stress. Mitochondria from Δyfh1
cells had higher oxidized protein levels than wild-type cells
(Fig. 2A), consistent with a major disturbance of the capacity to de-
toxify ROS [46]. When wild-type cells were cultured in iron-rich me-
dium, the amounts of carbonylated proteins increased particularly in
the 25–80 kDa zone (Fig. 2A). Interestingly, there was no major effect
of iron on the distribution or abundance of oxidized proteins within
the mitochondria of mutant cells. Mutant cells, which accumulate
iron in a redox-inactive form within the mitochondria, may already
be adapted to conditions of excess iron and therefore present a re-
sponse to the addition of further iron different from that of wild-
type cells, consistent with the data shown in Fig. 1.
Excess iron in the culturemediumhad no effect on the proteasome or
Lon protease protein levels in the cells (Fig. 2B and C). However, iron
inhibited the 20S-proteasome activity of wild-type cells in a spectacular
manner (Fig. 2D). Lon protease activity also decreased, but to a lesser ex-
tent. When grown in the presence of excess iron, mutant cells displayed
only low levels of proteasome activity, accompanied by a slight increase
in Lon protease activity. Our results therefore conﬁrm that oxidative
stress occurs in both the cytosol and the mitochondria of mutant cells.
3.4. Increase in the number of mitochondrial proteins binding an anti-
glutathione antibody in frataxin-deﬁcient cells
The decrease in mitochondrial GSH/GSSG ratios (Table 1) may be
the result of a need for detoxiﬁcation of oxidative damage, and
hence protein thiol oxidation and/or glutathionylation may occur.
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216 A.L. Bulteau et al. / Biochimica et Biophysica Acta 1822 (2012) 212–225We investigated the binding of glutathione to mitochondrial proteins,
by lysing mitochondria, separating the proteins by nonreducing SDS-
PAGE and probing with a monoclonal anti-GSH antibody speciﬁcally
binding protein–glutathione adducts. Western blots (Fig. 3A) showed
that some proteins were recognized by the antibody under basalTable 1
Yeast and human frataxin-deﬁcient cells are submitted to severe mitochondrial glutathione-
under the Materials and methods section and the mitochondrial GSH/GSSG ratios were calc
All values listed are means of at least three determinations, and Student's t test was used to
or controls).
Yeast cells
WT WT+Fe
(n=4) (n=3)
Total glutathione (nmol glutathione/mg protein) 11.7±1.8 ⁎⁎39.2±4.
GSH/GSSG 22.6 23.3conditions (WT cells), consistent with a role for glutathionylation as
a response to normal signaling events not related to stress conditions
[17,50–52]. The amounts of proteins binding to the antibody were
signiﬁcantly higher in Δyfh1 cells (Fig. 3A), suggesting that some pro-
teins within the mitochondria are speciﬁc targets for glutathionedependent oxidative stress. Yeast and human mitochondria were puriﬁed as described
ulated using the following equation: GSH/GSSG=2[(total glutathione)−GSSG]/GSSG.
identify signiﬁcant differences (⁎pb0.0001 and ⁎⁎pb0.05 respectively compared to WT
Human lymphoblasts
Δyfh1 Δyfh1+Fe Control Patients
(n=6) (n=6) (n=3) (n=3)
8 ⁎45.8±2.8 ⁎106.0±15.8 6.3±1.2 ⁎⁎4.5±0.6
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Fig. 2. Effect of iron on 20S-proteasome and Lon protease activities in yeast wild-type and Δyfh1 cells. Cells were cultured on YNB-medium, with and without supplementation with
100 μM iron citrate. A) Levels of carbonylated proteins were determined by oxyblot in isolated mitochondria, as described in the Materials and methods section (10 μg protein was
loaded in each lane); B) overall Lon protease/Pim1 abundance was assessed by blotting with a speciﬁc polyclonal antibody. C) Overall proteasome levels were assessed by blotting
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versus WT).
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was different for mutant cells grown in the presence of excess iron.
This suggests again that mutant cells have a different protein regula-
tion response to iron than that observed in wild-type cells.
We also investigated whether glutathione binding to mitochondrial
proteins also occurred in patients with Friedreich's ataxia or was speciﬁc
to yeast cells lacking frataxin. We used the same monoclonal anti-GSH
antibody to investigate the protein targets of glutathione binding in mi-
tochondria fromFRDA lymphoblasts. Larger numbers of proteins binding
to the antibody were detected in the mitochondria of patients than in
controls, and the broad pattern of bands observed in Fig. 3C suggests a
general process affecting proteins within the mitochondria. In addition,
speciﬁc proteins seemed to be the major targets of glutathione binding
in human lymphoblasts, with main bands corresponding to proteins of
150, 85, 50 and 37 kDa (Fig. 3C).3.5. Evidence for mitochondrial thiol modiﬁcations in yeast
frataxin-deﬁcient cells
Mitochondrial proteinswith potential thiol oxidation/glutathionyla-
tion were puriﬁed through the use of a “biotin/Grx switch” technique
[7,47,53]. This method is based on the use of an Escherichia coli glutare-
doxin that reduces not only glutathione–proteins but also disulﬁde
bridges in vitro in the presence of GSH [18] and is thus not only picking
up glutathionylated proteins, but also protein–protein mixed disul-
ﬁdes. We used Grx2 here because this isoform, unlike other Grx iso-
forms, is relatively insensitive to oxidative inactivation, making it an
effective enzyme for dynamic oxidative environments, such as that
found in mitochondria [54]. In this procedure, mitochondrial proteins
were ﬁrst heavily alkylated with N-ethyl maleimide (NEM), to block
all free •SH groups (Diagram 1). The thiol groups were then reduced
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Fig. 3. Analysis of glutathione conjugates by western blotting in isolated mitochondria from Δyfh1 cells and human lymphoblasts of FRDA patients. A) Yeast mitochondrial proteins
were permeabilized in 0.1% Triton and treated with 1% 5-sulfosalicylic acid to stabilize the glutathione pools. They were resuspended in loading buffer, and 40 μg of protein was
separated by SDS-PAGE and electrotransferred to nitrocellulose. Glutathione conjugates were visualized by incubation with a speciﬁc monoclonal anti-glutathione antibody,
which was detected by enhanced chemiluminescence; B) the same membrane was probed for Pgk1 as a loading marker; C) equal amounts of lymphoblast mitochondrial proteins
(40 μg) were separated by SDS-PAGE and the proteins were transferred to nitrocellulose. Glutathione–protein conjugates were detected with a monoclonal anti-GSH antibody;
D) frataxin levels and cytochrome c levels (as loading control) were assessed by western blotting. Human frataxin was detected by probing the membrane with a speciﬁc polyclonal
antibody. The blots are representative of three separate experiments.
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tinylated fractions were puriﬁed by afﬁnity chromatography on
streptavidin-agarose beads, and fractions bound to the resin were sub-
jected to trypsic digestion, nano-LC separation and MS/MS. The recovery
of biotinylated proteins from the streptavidin-agarose resinwas validated
by the use of a horseradish peroxidase (HRP)-conjugated avidin and, for
each sample, the same amount of total protein was subjected to MS–MS
analyses.
The summary of proteins identiﬁed in the biotinylated fractions
(Table 2) provides data speciﬁcally for mitochondrial proteins, but it
also includes actin, which was consistently found in our fractions, as
a physiological control, as actin is the main protein known to be
glutathionylated in patients with Friedreich's ataxia [33,55]. More
mitochondrial proteins were identiﬁed in the biotinylated fractions
of Δyfh1 cells than in the wild-type (Table 2). Interestingly, in mutant
cells, most of the proteins detected using the proteomic approach
corresponded to key enzymes in mitochondrial metabolism and
cell bioenergetics: the iron–sulfur enzyme aconitase, pyruvate dehy-
drogenase, α-ketoglutarate dehydrogenase, malate dehydrogenase
and complexes of the mitochondrial respiratory chain (pseudo-
complex I NADH-ubiquinone oxidoreductase, cytochrome b–c1 com-
plex III and cytochrome c oxidase complex IV subunits, ATP synthase).
Since our method is not picking up only glutathionylated proteins
but also mixed disulﬁdes, these results suggest that several mitochon-
drial proteins undergo thiol oxidation in frataxin-deﬁcient cells, with
some possibly glutathionylated, maybe in response to changes in intra-
cellular glutathione levels.S-maleimidP
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Diagram 1. Schematic representationIn iron-rich medium, only a few proteins were identiﬁed in bioti-
nylated fractions of mutant cells, including mitochondrial peroxire-
doxin and isocitrate dehydrogenase subunits (Table 2). Inversely,
key metabolic enzymes such as respiratory chain complexes and aco-
nitase were detected in wild-type cells grown in iron excess condi-
tions, but also the heat shock protein HSP78, consistent with the
oxidative stress status of the cells. These data suggest again that mu-
tant cells have a different protein regulation response to iron than
that observed in wild-type cells.
Some of the proteins detected in the proteomic screen of Table 2
were subjected to immunodetection with speciﬁc antibodies, after
puriﬁcation of mitochondrial proteins with the “biotin/Grx switch”
procedure describe above (Diagram 1). We chose to focus on speciﬁc
mitochondrial enzymes known to be affected in Friedreich's ataxia:
two enzymes of the TCA cycle, aconitase and α-ketoglutarate dehy-
drogenase (KGDH), and complex III (b–c1 complex) and complex IV
(cytochrome c oxidase) of the respiratory chain (Fig. 4) [57,58]. The
recovery of biotinylated proteins from the streptavidin-agarose resin
was validated by the use of a horseradish peroxidase (HRP)-conjugated
avidin and control experiments were performed in the presence of
all reagents except glutaredoxin. More intense bands were detected
after Grx/GSH treatment than in the absence of Grx (Fig. 4A).
A general deﬁcit of [Fe–S] cluster proteins, such as aconitase, is a
phenotype classically associated with a lack of frataxin. Biotinylated
(fractions bound to the streptavidin-agarose beads) and nonbiotiny-
lated fractions (not bound to the streptavidin-agarose beads) were
subjected to immunodetection with a speciﬁc antibody directedP
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Fig. 4.Mitochondrial proteins identiﬁedwith the biotin/Grx switch assay in yeastΔyfh1 cells: effect of iron excess. A) Biotin/Grx-switch controls: lane 1:wild-typemitochondrial proteins
(40 μg)were puriﬁed by the biotin/Grx-switch procedure and the biotinylated fractionwas probedwith an HRP-conjugated streptavidin; lane 2: Grxwas left out of the biotin-switch pro-
cedure: after NEM blockade, wild-typemitochondrial proteins (40 μg) were treatedwith GSH alone, and the biotinylated fraction was probed with an HRP-conjugated streptavidin; B) to
D) biotin/Grx-switch experiments: biotinylated proteins (bound to streptavidin-agarose beads), and nonbiotinylated proteins (not bound to streptavidin-agarose beads) were evaluated
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oxidase) antibody. Quantitative densitometric analyseswere performed for the separate experiments, with Image J software, and the band intensities are shown in black (nonbiotinylated
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219A.L. Bulteau et al. / Biochimica et Biophysica Acta 1822 (2012) 212–225against yeast aconitase. The presence of aconitase in biotinylated
fractions of mutant cells (Fig. 4B) suggests thiol oxidation of the
protein, in agreement with Table 2. Interestingly, the 83 kDa band
disappeared when mutant cells were grown in the presence of ex-
cess iron, consistent with Table 2 and Fig. 3, suggesting degradation
of the enzyme in these conditions (see Suppl. Data 1).
Western blotting showed that only small amounts of complex III
(Fig. 4C) and complex IV (Fig. 4D) were present in the biotinylated
fractions of wild-type cells, which have a functional mitochondrial re-
spiratory chain. The amounts of both complexes present in biotiny-
lated fractions were greater in mutant cells, as shown by the intense
23 kDa band corresponding to a subunit of the bc1 complex, and the
17 kDa band corresponding to the cytochrome c oxidase subunit.
These results suggest that the intense band at about 43 kDa detected
with the anti-GSH antibody (Fig. 3) might be attributed to complex
III. Both proteins were also detected when wild-type and mutant
cells were grown in the presence of excess iron, suggesting thiol oxi-
dation (Fig. 4C–D).
As α-ketoglutarate dehydrogenase (KGDH) has been described as
a glutathionylation target in various biological systems [47,56] and
found in the proteomic screen of Table 2, we also tested for biotiny-
lated KGDH, with polyclonal antibodies speciﬁc for the E1, E2 andE3 subunits of the enzyme (Fig. 5). We detected no bands in wild-
type cells (data not shown). However, we clearly observed signiﬁcant
bands in biotinylated fractions corresponding to the E1 subunit, con-
sistent with Table 2, and, to a lesser extent, the E3 and E2 subunits of
KGDH in Δyfh1 cells (Fig. 5). In the presence of excess iron, a different
response was observed for KGDH: E1 subunit bands were less intense
and we no longer detected the band corresponding to the E2 subunit.
However, we cannot exclude the possibility that the antibody cannot
recognize the oxidized form of the lipoic acid cofactor.
3.6. Evidence for mitochondrial thiol modiﬁcations in the lymphoblasts of
FRDA patients
For the identiﬁcation of these protein targets, mitochondria were
puriﬁed from the lymphoblasts of FRDA patients, submitted to the
“biotin/Grx-switch” protocol described above (Diagram 1) and sub-
jected to immunodetection with speciﬁc antibodies. The differences
in band intensities observed in the mitochondria of the FRDA patients
(Fig. 6) suggest that the degree of thiol oxidation in aconitase may de-
pend on the patient. The E2 subunit of KGDH was also detected in the
biotinylated fractions, conﬁrming the role of this protein as a major
target of protein thiol modiﬁcations in frataxin-deﬁcient cells. Bands
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Fig. 5. KGDH subunits identiﬁed with the biotin/Grx switch assay in yeast Δyfh1 cells: effect of excess iron. Mitochondrial proteins were puriﬁed by the biotin/Grx switch technique
described in Materials and methods. A) Biotinylated proteins (bound to avidin-agarose beads), and nonbiotinylated proteins (not bound to avidin-agarose beads) were evaluated by
western blotting with polyclonal antibodies against E1, E2, and E3 KGDH subunits; B) the bands were quantiﬁed by densitometry with Image J software and the graph shows the
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220 A.L. Bulteau et al. / Biochimica et Biophysica Acta 1822 (2012) 212–225which may correspond to these two proteins were detected in Fig. 3,
suggesting that part of the thiol oxidation may be due to a glutathio-
nylation process. No thiol oxidation of complexes III and IV was
detected in FRDA patients (data not shown).
3.7. Effect of iron excess and thiol oxidation on mitochondrial metabolic
status of yeast Δyfh1 cells
We investigated the effects of excess iron on the state 3
(ADP-dependent) rates of respiration fuelled by NADH, succinate
or pyruvate/malate, using intact mitochondria from wild-type andBiotinylated Non biotinylated
C P C P
Biotinylated Non biotinylated
C P C P
A
B
Fig. 6. pboard1Mitochondrial proteins identiﬁedwith the biotin/Grx switch assay in the lymphobla
described inMaterials andmethods. The biotinylated proteins bound to streptavidin-conjugated ag
aconitase and B) a polyclonal antibody against the E2 subunit of KGDH. The bands were quantiﬁe
(nonbiotinylated fractions) and gray (biotinylated fractions).frataxin-deﬁcient cells. As expected, mutant cells displayed impaired
mitochondrial respiration (Table 3). The addition of iron resulted in a
decrease in the respiration of wild-type mitochondria in the presence
of the three electron donors, despite the rho+ status of most of the
cells. Pyruvate/malate was the only substrate of the three tested that
was entirely dependent on the integrity of enzyme functions in the
TCA cycle for the provision of electrons to themitochondrial respiratory
chain. Mitochondrial respiration in the presence of pyruvate/malate
decreased in the presence of excess iron. This decrease in mito-
chondrial respiration may be accounted for by the thiol oxidation
of pyruvate dehydrogenase, which shares a subunit with KGDH.Aconitase
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221A.L. Bulteau et al. / Biochimica et Biophysica Acta 1822 (2012) 212–225However, iron had no effect on mitochondrial respiration in frataxin-
deﬁcient cells, with no dependence on the electron donor of the
respiratory chain, demonstrating a difference in the response of
wild-type and mutant cells to the presence of excess iron.
We tested the hypothesis of a glutathionylation process, by mea-
suring the speciﬁc activities of aconitase, KGDH, ubiquinol cytochrome
c oxidoreductase (complex III) and cytochrome c oxidase (complex IV)
and isocitrate dehydrogenase (ISDH) (Fig. 7). We also assessed the
effects of glutaredoxin on the activity of these ﬁve enzymes, which
catalyze important steps of the TCA cycle and respiratory chain. As
reported in previous studies, frataxin depletion dramatically decreasedA B
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Fig. 7. Effect of changes in thiol-redox status and excess iron on the activities of key metabol
supplementation with 100 μM iron citrate. Mitochondria were then isolated and disrupted,
bars: enzymatic activities before glutaredoxin treatment. Gray bars: enzymatic activities aft
hydrogenase (KGDH) activity; C) ubiquinol-cytochrome c oxidoreductase (complex III) activ
activity. All data points in the ﬁgure are the means of at least three determinations, and areaconitase activity and the residual aconitase activity of mutant cells
was not restored by glutaredoxin treatment (Fig. 7A), consistent with
a possible defect in iron–sulfur cluster biogenesis in mutant cells. In
wild-type cells, the addition of iron led to the inhibition of aconitase,
which was not affected by glutaredoxin.
Changes in KGDH activity are of particular interest, because many
degenerative processes have been associated with a loss of KGDH ac-
tivity, although the role of this enzyme in Friedreich's ataxia remains
unclear [59–61]. The KGDH activity of wild-type cells was not affected
by the addition of excess iron to the growth medium (Fig. 7B). Con-
versely, the culture of mutant cells in the presence of excess ironKGDH
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ity; D) cytochrome c oxidase (complex IV) activity. E) Isocitrate dehydrogenase (ISDH)
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Table 2
Summary of proteins identiﬁed in the biotinylated fractions of the biotin/Grx switch
assay.
Identiﬁed proteinsa Genesb Accession
numbersc
Mascott
scoresd
No. of
sequenced
peptidese
wt
V-type proton ATPase
subunit B
VMA2 VATB_YEAST 89 1
D-Lactate dehydrogenase
[cytochrome] 1
DLD1 DLD1_YEAST 84 1
wt+Fe
Actin ACT1 ACT1_YEAST 224 2
Aconitate hydratase
(aconitase)
ACO1 ACON_YEAST 117 2
Cytochrome c oxidase
polypeptide 5A
COX5A COX5A_YEAST 100 1
Cytochrome b–c1 complex
subunit 1
COR1 QCR1_YEAST 89 1
Mitochondrial outer membrane
protein porin 1
POR1 VDAC1_YEAST 80 2
Heat shock protein 78 HSP78 HSP78_YEAST 55 1
Acetyl-CoA carboxylase FAS3 ACAC_YEAST 54 1
Adenylate cyclase CYR1 CYAA_YEAST 49 1
Protoporphyrinogen oxidase HEM14 PPOX_YEAST 43 1
Δyfh1
Cytochrome c oxidase subunit 4 COX4 COX4_YEAST 319 3
Actin ACT1 ACT1_YEAST 257 2
Cytochrome c oxidase
polypeptide 5A
COX5A COX5A_YEAST 186 2
ATP synthase subunit alpha ATP1 ATPA_YEAST 176 2
Aconitate hydratase (aconitase) ACO1 ACON_YEAST 175 2
ATP synthase subunit e ATP21 ATPJ_YEAST 144 1
Cytochrome b–c1 complex
subunit 10
QCR10 QCR10_YEAST 140 2
Malate dehydrogenase MDH1 MDHM_YEAST 129 2
ATP synthase subunit beta ATP2 ATPB_YEAST 122 2
Cytochrome c oxidase subunit 2 COX2 COX2_YEAST 122 1
Cytochrome b–c1 complex
subunit 1
COR1 QCR1_YEAST 99 2
Cytochrome b–c1 complex
subunit 7
QCR7 QCR7_YEAST 93 1
Homocitrate synthase LYS21 HOSM_YEAST 87 1
External NADH-ubiquinone
oxidoreductase 1
NDE1 NDH1_YEAST 81 1
Cytochrome b–c1 complex
subunit 6
QCR6 QCR6_YEAST 80 1
Pyruvate dehydrogenase E1
component subunit α
PDA ODPA_YEAST 78 2
ATP synthase subunit gamma ATP3 ATPG_YEAST 51 1
α-Ketoglutarate dehydrogenase
E1 component
KGD1 ODO1_YEAST 37 1
Δyfh1+Fe
Actin ACT1 ACT1_YEAST 292 3
Ketol-acid reductoisomerase ILV5 ILV5_YEAST 102 2
Heat shock protein 78 HSP78 HSP78_YEAST 97 1
Phosphoglycerate kinase PGK1 PGK_YEAST 88 3
Isocitrate dehydrogenase
[NAD] subunit 1
IDH1 IDH1_YEAST 78 1
Mitochondrial peroxiredoxin PRX1 PRX1_YEAST 54 2
Isocitrate dehydrogenase
[NADP]
IDP1 IDHP_YEAST 52 3
a Proteins identiﬁed by MS and MS/MS (see more details in Materials and methods
and Supplemental proteomic data).
b Genes correspond to gene names found in SGD (Saccharomyces Genome Database).
c Swiss prot protein database accession numbers.
d Mascott scores obtained for protein identiﬁcation using combined MS and MS/MS
peak lists (see more details in Materials and methods and Supplemental proteomic
data). Only the proteins with Mascott scores≥37 were considered.
e Number of sequenced peptides.
Table 3
Mitochondrial respiration of wild-type and frataxin-deﬁcient cells in the presence
of various electron donors. The oxygen consumption of isolated mitochondria was
measured as described under the Materials and methods section, in the presence
of various electron donors: NADH (10 mM), succinate (10 mM), or pyruvate/malate
(10 mM/2.5 mM). The rates of oxygen consumption are expressed in nmol oxygen/min/
mg protein, and the values listed are means of at least three determinations. Student's t
test was used to identify signiﬁcant differences (⁎pb0.001 and ⁎⁎pb0.005 versus wild-
type).
Mitochondrial respiration (nmol O2/min/mg protein)
NADH Succinate Pyruvate/malate
WT 175.0±6.5 85.6±21.4 177.5±12.0
WT+Fe ⁎70.3±7.3 ⁎⁎48.9±7.2 ⁎16.6±3.9
Δyfh1 ⁎32.7±5.7 ⁎22.7±0.8 ⁎22.2±6.7
Δyfh1+Fe ⁎47.6±8.1 ⁎33.7±4.6 ⁎2.1±2.6
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store levels of KGDH activity (Fig. 7B). Isocitrate dehydrogenasesubunits were also found in biotinylated fractions of mutant cells
grown in iron excess conditions (Table 2). The NADP-dependent iso-
form of ISDH can produce NADPH, which has been shown to be de-
pleted in Δyfh1 cells [28]. There was no change in ISDH activity of
mutant cells compared to the wild-type (Fig. 7E). In presence of ex-
cess iron, ISDH activity was signiﬁcantly decreased in wild-type
cells but remained unchanged in mutant cells, which conﬁrms again
the different response of Δyfh1 cells to iron excess conditions.
Ubiquinol-cytochrome c oxidoreductase activity (complex III) was
unaffected in mutant cells (Fig. 7C), despite their severe respiratory
deﬁciency (Table 3). By contrast, cytochrome c oxidase activity levels
were lower in frataxin-deﬁcient cells than in the wild-type (Fig. 7D).
In Δyfh1 cells, cytochrome c oxidase activity seemed to be slightly re-
stored by glutaredoxin treatment and was not dependent on iron.
When wild-type cells were cultured in iron-rich medium, cytochrome
c oxidase activity was inhibited, indicating that excess iron inhibits
the last step of the mitochondrial respiratory chain (Fig. 7D). This ac-
tivity was restored by glutaredoxin treatment, strongly suggesting
that a reversible glutathionylation process may be involved in cyto-
chrome c oxidase regulation in oxidative stress conditions.
4. Discussion
In this study, we show evidence for a severe mitochondrial
glutathione-dependent oxidative stress and thiol oxidation of key mi-
tochondrial proteins in yeast frataxin-deﬁcient cells and the lympho-
blasts of FRDA patients. We also show that, in yeast, glutathione was
imported into the mitochondria when mutant cells were grown in
iron-rich medium (Fig. 1 and Diagram 2). As mutant cells accumulate
iron within the mitochondria, our data conﬁrm the existence of a sig-
naling and/or regulatory process involving both iron and glutathione,
as suggested in previous studies [36,62], leading to a dynamic ﬂux of
glutathione into mitochondria or a decrease in glutathione export,
protecting mitochondrial proteins against oxidative damage.
The high intramitochondrial GSH/GSSG ratio of wild-type cells
minimizes protein glutathionylation by thiol disulﬁde exchange
[63]. When the GSH/GSSG ratio decreases, high GSSG concentrations
have been shown to promote glutathionylation through the forma-
tion of mixed disulﬁdes by thiol-disulﬁde exchange between protein
sulfhydryl groups and GSSG, thereby protecting critical SH groups
from irreversible oxidation to sulﬁnic and sulfonic acids [1–5]. How-
ever, minor changes in the intracellular GSH/GSSG ratio are unlikely
to lead to substantial S-glutathionylation of proteins according to
thiol–disulphide exchange involving GSSG and protein thiols. Indeed,
the redox potential of most cysteine residues is such that the ratio of
GSSG versus GSH in cells would need to change dramatically to in-
duce S-glutathionylation [64,65]. Δyfh1 mutant yeast cells are sub-
jected to severe mitochondrial oxidative stress, with a GSH/GSSG
ratio of 1.7 within the mitochondria (Table 1). In these cells, we
could not detect GSSG export as a protective mechanism against
cytosol
GSH / GSSG
Fe
GSH
KGDH-S-ox
Aconitase-S-ox
Proteasome
OP
T1
GSH / GSSG
CIV
-S-ox
QPseudo
C I
C III
-S-ox
C II
Frataxin
TCA cycle
ROS
Impaired Fe-S 
formation
Oxidized proteins
Gpx
ISDH-S-ox
Diagram 2. Schematic representation of the cellular mechanisms associated with frataxin deﬁciency. Frataxin deﬁciency leads to primary mitochondrial iron–sulfur clusters
(ISC) deﬁcits and mitochondrial iron overload. The defective ETC leads to more ROS production and oxidative stress, including increase in GSSG levels within the mitochondria,
decrease in proteasome activity and increase of oxidized proteins. S-ox represents here the thiol oxidation of proteins, some of them possibly glutathionylated.
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redox potential [28] thus one hypothesis could be that, in frataxin-
deﬁcient cells, the formation of glutathione-mixed disulﬁdes may
limit the change of the redox state to a more positive potential
which could be detrimental for the cell.
Recently, proteomic approaches have allowed the global identiﬁ-
cation of protein targets of glutathionylation [8,10,12,13,66]. Howev-
er, in yeast, very few studies have addressed the analysis of this
process [67,68]. Our proteomics and immunodetection experiments
are consistent with the occurrence of thiol oxidation of enzymes of
the TCA cycle — aconitase and α-ketoglutarate dehydrogenase —
and subunits of respiratory chain complexes III and IV in yeast
Δyfh1 cells. We also observed thiol modiﬁcations to aconitase and
KGDH in the lymphoblasts of FRDA patients. As Grx can reduce disul-
ﬁde bonds, the “biotin/Grx switch” procedure is not restricted to glu-
tathionylated proteins. However, we observed an increase of the
number of proteins binding to an anti-glutathione antibody in both
yeast Δyfh1 cells and human lymphoblasts (Fig. 3). We are currently
alternative running mass spectrometry experiments to try to deter-
mine the mass shift associated with the protein oxidation of these po-
tential mitochondrial targets.
The exact mechanism(s) leading to glutathionylation in vivo re-
main(s) unclear. The modiﬁcations are labile, difﬁcult to control and
may affect only a small proportion of the molecules of a particular
protein, thus the possible physiological role of this regulatory process
in mitochondrial bioenergetics deﬁciency remains to demonstrate.
Ubiquinol cytochrome c oxidoreductase (cytochrome bc1 complex
III) and cytochrome c oxidase (complex IV) activities respond to the
oxidative stress status of mitochondria and it has been shown in
human cells that overproduced GSSG might be able to react with
the thiol groups of respiratory chain complexes III and IV [17,51].
The thiol oxidation/glutathionylation of complex III could be physio-
logically relevant in Δyfh1 cells, because this complex is considered
to be a key site of electron leakage and superoxide formation during
oxidative phosphorylation in yeast. Moreover, the thiol oxidation of
cytochrome c oxidase is consistent with previous studies showing
that cytochrome c oxidase subunits are glutathionylated in responseto oxidative stress within human T lymphocytes and rat hepatocytes
[17,51].
The [4Fe–4S] iron–sulfur cluster of the aconitase active site is es-
sential for catalytic activity, but also renders aconitase highly suscep-
tible to reactive oxygen species (ROS) [69–74]. The loss of activity of
aconitase in mutant cells (Fig. 7) may be the consequence of a critical
protein modiﬁcation. Indeed, it has been suggested that aconitase ac-
tivity is modulated by glutathionylation and that the modiﬁcation of
cysteine residues close to the [4Fe–4S] cluster of aconitase may im-
pair enzyme activity [57,58]. Mutant cells had a different response
to iron excess conditions and aconitase is probably degraded in
these conditions. Moreover, aberrant iron–sulfur cluster formation
has been reported in mutant cells grown in iron-rich medium, poten-
tially accounting for the lack of detection of aconitase in biotinylated
fractions during immunodetection or proteomic experiments [46].
In our experimental conditions, the inactivation of mitochondrial
respiration was not due to a global disruption of respiratory enzyme
activity. Instead, it reﬂected the inactivation of KGDH and aconitase
(Table 3). A loss of NADH-linked respiration has been shown to be
closely correlated with the degree of inactivation of aconitase and
KGDH, and the redox-dependent modulation of KGDH would be
expected to limit the production of NADH and the entry of electrons
into the respiratory chain. We provide here evidence for thiol oxida-
tion of the E1 and E2 subunits of KGDH (Fig. 5). The reaction catalyzed
by KGDH makes use of the unique properties of the lipoic acid cofac-
tor covalently linked to the E2 subunit, but the cycling of sulfhydryl
groups on the E3 subunit between reduced and oxidized states is
also essential for catalysis. For this reason, the thiol oxidation of
both the E2 and E3 subunits would have a direct impact on the enzy-
matic activity of KGDH. It has also been shown that the treatment of
puriﬁed KGDH with GSSG leads to the glutathionylation of all three
KGDH subunits [75], and that glutathionylation of the highly reactive
E2 subunit results in a slight inhibition of enzymatic activity [47,56].
In addition, KGDH activity was slightly inhibited in mutant cells, con-
sistent with published ﬁndings for cellular models of the disease
[59–61]. The E3 subunit was also modiﬁed when mutant cells were
grown in iron-rich conditions, resulting in a greater loss of KGDH
224 A.L. Bulteau et al. / Biochimica et Biophysica Acta 1822 (2012) 212–225catalytic activity. These results strongly suggest that the enzymatic
activity of KGDH could be regulated by glutathionylation in yeast
frataxin-deﬁcient cells and human lymphoblasts.
5. Conclusions
Higher than normal levels of actin ﬁlament glutathionylation have
been observed, together with cytoskeletal abnormalities, in FRDA ﬁbro-
blasts [33,34]. In addition, it has recently been shown that Nrf2 (nuclear
factor-erythroid 2-related factor 2), which regulates cellular adaptation
to oxidative stress, is unresponsive in the ﬁbroblasts of patients with
FRDA [30]. In a recent review, it was suggested that the loss of GSH-
redox homeostasis may increase the level of S-glutathionylated pro-
teins, thereby deregulating the normal association of Nrf2/KEAP1
with cytoskeletal actin ﬁlaments and the antioxidant signaling path-
way [76]. We show here that proteins important for mitochondrial
metabolism are also targets of thiol oxidation, and that some of
them may be glutathionylated. The mechanism(s) involved here
are probably rather complex and the direct link with perturbations
of mitochondrial glutathione homeostasis remains to be elucidated.
However, we suggest that the thiol-dependent regulation of mito-
chondrial proteins plays an important role in the cellular signaling
and regulation of mitochondrial function in frataxin-deﬁcient cells.
Supplementary materials related to this article can be found online
at doi:10.1016/j.bbadis.2011.11.003.
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